vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and MERCANTILE BANK CORP (MBWM). Click either name above to swap in a different company.

Immunocore Holdings plc is the larger business by last-quarter revenue ($104.5M vs $67.6M, roughly 1.5× MERCANTILE BANK CORP). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs 9.1%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Tamilnad Mercantile Bank Limited (TMB) is an Indian bank headquartered at Thoothukudi, Tamil Nadu. TMB was founded in 1921 as the Nadar Bank, but changed its name to Tamilnad Mercantile Bank in November 1962 to widen its appeal beyond the Nadar community. The bank currently has 600 full branches throughout India, 12 regional offices and two link offices, two central processing centres, one service branch, four currency chests, 48 eLobby centres, 262 cash recycler machines and 1151 automated ...

IMCR vs MBWM — Head-to-Head

Bigger by revenue
IMCR
IMCR
1.5× larger
IMCR
$104.5M
$67.6M
MBWM
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
9.1%
MBWM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IMCR
IMCR
MBWM
MBWM
Revenue
$104.5M
$67.6M
Net Profit
$22.7M
Gross Margin
97.4%
Operating Margin
-18.8%
Net Margin
33.6%
Revenue YoY
24.3%
Net Profit YoY
16.1%
EPS (diluted)
$-0.61
$1.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
MBWM
MBWM
Q1 26
$67.6M
Q4 25
$104.5M
$62.1M
Q3 25
$103.7M
$62.4M
Q2 25
$98.0M
$60.9M
Q1 25
$93.9M
$57.3M
Q4 24
$84.1M
$58.5M
Q3 24
$80.2M
$58.0M
Q2 24
$75.4M
$56.8M
Net Profit
IMCR
IMCR
MBWM
MBWM
Q1 26
$22.7M
Q4 25
$22.8M
Q3 25
$-177.0K
$23.8M
Q2 25
$-10.3M
$22.6M
Q1 25
$5.0M
$19.5M
Q4 24
$19.6M
Q3 24
$8.7M
$19.6M
Q2 24
$-11.6M
$18.8M
Gross Margin
IMCR
IMCR
MBWM
MBWM
Q1 26
Q4 25
97.4%
Q3 25
99.5%
Q2 25
98.9%
Q1 25
99.1%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
97.7%
Operating Margin
IMCR
IMCR
MBWM
MBWM
Q1 26
Q4 25
-18.8%
42.0%
Q3 25
-6.9%
44.0%
Q2 25
-15.2%
42.6%
Q1 25
-3.9%
42.0%
Q4 24
-23.1%
39.7%
Q3 24
-10.6%
42.4%
Q2 24
-21.2%
41.4%
Net Margin
IMCR
IMCR
MBWM
MBWM
Q1 26
33.6%
Q4 25
36.8%
Q3 25
-0.2%
38.1%
Q2 25
-10.5%
37.1%
Q1 25
5.4%
34.1%
Q4 24
33.5%
Q3 24
10.9%
33.8%
Q2 24
-15.4%
33.1%
EPS (diluted)
IMCR
IMCR
MBWM
MBWM
Q1 26
$1.32
Q4 25
$-0.61
$1.41
Q3 25
$0.00
$1.46
Q2 25
$-0.20
$1.39
Q1 25
$0.10
$1.21
Q4 24
$-0.47
$1.20
Q3 24
$0.17
$1.22
Q2 24
$-0.23
$1.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
MBWM
MBWM
Cash + ST InvestmentsLiquidity on hand
$864.2M
Total DebtLower is stronger
$1.5M
Stockholders' EquityBook value
$381.0M
$736.9M
Total Assets
$1.1B
$6.9B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
MBWM
MBWM
Q1 26
Q4 25
$864.2M
Q3 25
$892.4M
Q2 25
$882.8M
Q1 25
$837.0M
Q4 24
$820.4M
Q3 24
$901.3M
Q2 24
$859.6M
Total Debt
IMCR
IMCR
MBWM
MBWM
Q1 26
$1.5M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$438.7M
Q2 24
$452.5M
Stockholders' Equity
IMCR
IMCR
MBWM
MBWM
Q1 26
$736.9M
Q4 25
$381.0M
$724.9M
Q3 25
$396.6M
$657.6M
Q2 25
$388.5M
$631.5M
Q1 25
$378.5M
$608.3M
Q4 24
$360.7M
$584.5M
Q3 24
$377.8M
$583.3M
Q2 24
$359.1M
$551.2M
Total Assets
IMCR
IMCR
MBWM
MBWM
Q1 26
$6.9B
Q4 25
$1.1B
$6.8B
Q3 25
$1.1B
$6.3B
Q2 25
$1.1B
$6.2B
Q1 25
$1.0B
$6.1B
Q4 24
$1.0B
$6.1B
Q3 24
$1.1B
$5.9B
Q2 24
$1.0B
$5.6B
Debt / Equity
IMCR
IMCR
MBWM
MBWM
Q1 26
0.00×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.16×
Q2 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
MBWM
MBWM
Operating Cash FlowLast quarter
$-32.7M
Free Cash FlowOCF − Capex
$-35.5M
FCF MarginFCF / Revenue
-34.0%
Capex IntensityCapex / Revenue
2.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-15.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
MBWM
MBWM
Q1 26
Q4 25
$-32.7M
$18.0M
Q3 25
$-4.5M
$23.1M
Q2 25
$26.0M
$-7.8M
Q1 25
$435.0K
$-3.0M
Q4 24
$-14.0M
$101.1M
Q3 24
$21.1M
$-8.1M
Q2 24
$23.5M
$9.1M
Free Cash Flow
IMCR
IMCR
MBWM
MBWM
Q1 26
Q4 25
$-35.5M
Q3 25
$-5.2M
Q2 25
$25.6M
Q1 25
$137.0K
Q4 24
$-17.5M
Q3 24
$20.3M
Q2 24
$23.1M
FCF Margin
IMCR
IMCR
MBWM
MBWM
Q1 26
Q4 25
-34.0%
Q3 25
-5.0%
Q2 25
26.1%
Q1 25
0.1%
Q4 24
-20.9%
Q3 24
25.3%
Q2 24
30.7%
Capex Intensity
IMCR
IMCR
MBWM
MBWM
Q1 26
Q4 25
2.8%
Q3 25
0.7%
Q2 25
0.4%
Q1 25
0.3%
Q4 24
4.3%
Q3 24
1.0%
Q2 24
0.4%
Cash Conversion
IMCR
IMCR
MBWM
MBWM
Q1 26
Q4 25
0.79×
Q3 25
0.97×
Q2 25
-0.35×
Q1 25
0.09×
-0.15×
Q4 24
5.15×
Q3 24
2.42×
-0.41×
Q2 24
0.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMCR
IMCR

Segment breakdown not available.

MBWM
MBWM

Net Interest Income$55.9M83%
Noninterest Income$11.7M17%

Related Comparisons